CEO
H. LUNDBECK A/S
Equibles does not estimate personal net worth.
Charles van Zeele is recorded as CEO at H. LUNDBECK A/S. Charles van Zeele has spoken on 2 earnings calls across 1 company, most recently for H. LUNDBECK A/S on August 19, 2026. H. LUNDBECK A/S is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“I'm, of course, pleased to have my executive leadership team join me today, whom I'll be introducing very shortly. So, just a few opening remarks before we get into the main presentation.”
“Of course, it's my pleasure to really present to you our outstanding results. It's been, again, another record year for Lundbeck in 2025, and it's really underpinned by very strong fundamentals, very much underpinned by our focused innovator strategic path.”
H. LUNDBECK A/S
CEO
Transcript header (unverified)
H. LUNDBECK A/S
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Get Visual - Lundbeck Financial statements for the first six months of 2026
H. LUNDBECK A/S
Lundbeck Financial statements for the full year 2025
H. LUNDBECK A/S
